Experiment 69170
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Cimicifuga racemosa (RANUNCULACEAE) |
| Citation | WUTTKE,W: SEIDLOVA WUTTKE,D: GORKOW,C:. (2003). THE CIMICIFUGA PREPARATION BNO 1055 VS. CONJUGATED ESTROGENS IN A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY; EFFECTS ON MENOPAUSE SYMPTOMS AND BONE MARKERS.. 44(S1) |
| Amount utilized | |
| Compound isolated | |
| Disease | SIXTY-TWO EVALUABLE POSTMENOPAUSAL WOMEN WERE INCLUDED IN THE DOUBLE-BLIND, RANDOMIZED, MULTICENTRE STUDY, CR BNO 1055 PROVED TO BE EQUIPOTENT TO CE AND SUPERIOR TO PLACEBO IN REDUCING CLIMACTERIC COMPLAINTS. UNDER BOTH PREPARATIONS, BENEFICIAL EFFECTS ON BONE METABOLISM HAVE BEEN OBSERVED IN THE SERUM. CR BNO 1055 HAD NO EFFECT ON ENDOMETRIAL THICKNESS, WHICH WAS SIGNIFICANTLY INCREASED BY CE. VAGINAL SUPERFICIAL CELLS WERE INCREASED UNDER CE AND CR BNO 1055 TREATMENT. THE RESULTS CONCERNING CLIMACTERIC COMPLAINTS AND ON BONE METABOLISM INDICATE AN EQUIPOTENT EFFECT OF CR BNO 1055 IN COMPARISON TO 0.6 MG CE PER DAY. |
| Dose amount | 40.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | HYDRO-ALCOHOLIC EXT |
| Gender | FEMALE |